1SXP.XETRA SCHOTT Pharma AG & Co. KGaA

Healthcare Medical Instruments & Supplies XETRA Stock Exchange
21.85 EUR
Close of Nov 5, 2026
12.62 26.20
Market cap
EUR 3.29B
P/E
24.3x
P/B
3.63x
ROE
13.7%
Dividend yield
0.73%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Jun 2026.

Is 1SXP.XETRA undervalued?

Graham number
Price21.85
Graham value11.04
Premium97.9%

1SXP.XETRA trades 97.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SCHOTT Pharma AG & Co. KGaA fundamental analysis

No fundamental analysis for SCHOTT Pharma AG & Co. KGaA yet.

SCHOTT Pharma AG & Co. KGaA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatm…

Full company profile